Mobility Ventures LLC, designer and manufacturer of the MV-1, the only American vehicle purpose-built and designed from the ground up in support of people who use wheelchairs, is showcasing its vehicles at the 2014 BusCon Expo in Indianapolis. BusCon, North America’s largest bus show, will be held Sept. 16 to 17, 2014, at the Indiana Convention Center in Halls F and G.

RELATED: MV-1 dealership network reaches milestone

Mobility Ventures will be at BusCon showcasing two models of the MV-1 — its standard DX model and its new LX luxury model. The vehicles, both of which meet or exceed the vehicle guidelines of the Americans with Disabilities Act, can be seen at Booth #501.

“We are excited to be at BusCon 2014 and to introduce some of our very latest design upgrades, including the MV-1 LX and all that it has to offer in luxury fleet transportation for people who use wheelchairs,” said John Walsh, Mobility Ventures VP, sales and marketing. “This vehicle is redefining choice in luxury fleet options.”

The BusCon Expo is an annual exhibition where industry professionals who own or operate buses for public agencies and private companies come together to see the latest equipment, technology and services in mass transit and paratransit.  

Mobility Venture’s MV-1 meets all applicable Federal Motor Vehicle Safety Standards direct from the factory with no modifications. Additionally, the MV-1 is more durable and cost-effective to own and operate than a traditional retrofitted van or bus, according to the company. The vehicle is designed to transport all passengers including those with disabilities, making it the perfect solution for both consumer and commercial fleet services.

For more information on Mobility Ventures LLC and the MV-1, visit www.mv-1.us

About the author
Staff Writer

Staff Writer

Editorial

Our team of enterprising editors brings years of experience covering the fleet industry. We offer a deep understanding of trends and the ever-evolving landscapes we cover in fleet, trucking, and transportation.  

View Bio
0 Comments